Form 4 for TXG 10x Genomics, Inc.
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001610717-26-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | 2026-02-23 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $18.58 | -9,632 | 1.06M | -0.9% | -$179.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-23 | S | D | 9,632 | $18.58 | 1,061,924 | D | — | — |